Expression of the Apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy

The TNM Classification of Malignant Tumours

1974 • 1,091 citations

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

1992 • 1,063 citations

Urologic pathology: The prostate

1977 • 821 citations

A computer program for comparing K samples with right-censored data

1972 • 731 citations

Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview

1992 • 600 citations

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1993 • 597 citations

Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence.

1993 • 390 citations

Expression of bcl-2 in fetal tissues suggests a role in morphogenesis.

1993 • 320 citations

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1992 • 317 citations

Control of programmed cell death in normal and leukemic cells: new implications for therapy

1993 • 297 citations

Lymphocyte infiltrates as a prognostic variable in female breast cancer

1992 • 283 citations

BCL‐2 expression in adult and embryonic non‐haematopoietic tissues

1993 • 265 citations

Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells.

1994 • 190 citations

Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosis

1995 • 156 citations

Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.

1993 • 144 citations

Apoptosis in bladder cancer as related to standard prognostic factors and prognosis

1994 • 143 citations

Expression of bcl-2 and the progression of human and rodent prostatic cancers.

1996 • 139 citations

The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status

1994 • 126 citations

Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer

1993 • 123 citations

Volume Corrected Mitotic Index (M/V-INDEX)

1989 • 118 citations

Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues

1993 • 107 citations

The bcl-2 oncogene and apoptosis.

1992 • 90 citations

Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters

1992 • 75 citations

Reduced apoptotic cell death in follicular lymphoma

1991 • 59 citations

Mitotic activity, apoptosis and TRPM‐2 mRNA expression in dmba‐induced rat mammary carcinoma treated with anti‐estrogen toremifene

1993 • 58 citations

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy

1991 • 55 citations

Nuclear Deoxyribonucleic Acid Content Measured By Static Cytometry: Important Prognostic Association For Patients With Clinically Localized Prostate Carcinoma Treated By External Beam Radiotherapy

1992 • 49 citations

Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional‐cell bladder cancer

1993 • 36 citations

The Role of Bcl-2 in the Pathogenesis of B Chronic Lymphocytic Leukemia

1993 • 34 citations

Ultrastructural characteristics of human renal cell carcinoma in relation to the light microscopic grading.

1978 • 17 citations

Expression of retinoblastoma gene (Rb) protein in T12MO prostatic adenocarcinoma

1995 • 17 citations